SAN DIEGO–(BUSINESS WIRE)–$GNRC #GNRC—The Class: Robbins LLP reminds investors that a shareholder filed a class…
TOKYO, Dec 12, 2022 – (JCN Newswire) – Fujitsu today announced that it joined a…
– Data Suggest Long-term Treatment with PYRUKYND® in Adults with PK Deficiency is Associated with…
HONG KONG, Dec 12, 2022 – (ACN Newswire) – InvesTech Holdings Limited (“InvesTech Holdings”; together…
– 89% ORR in TKI-therapy naïve patients; 73% ORR in all evaluable patients with 27-week…
Transplanted hypoimmune (HIP)-modified allogeneic CD19-targeted CAR T cells control CD19+ tumor cells in fully immunocompetent…
Media Release COPENHAGEN, Denmark; December 11, 2022 Epcoritamab featured in multiple data disclosures, including four…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR…
RVU120 Demonstrates Single-Agent Activity with a Complete Response, 4 Blast Reductions, and 4 Erythroid and/or Platelet…
Vincerx’s proprietary payload and linker technology and VIP943, a novel anti-CD123 antibody drug conjugate (ADC),…
First Preclinical Data for IGM-2644 and IGM-2537 Featured in Poster Presentations MOUNTAIN VIEW, Calif., Dec….
Lanraplenib is being evaluated in ongoing Phase 1b/2 trial in combination with gilteritinib in patients…
A single dose of KT-253 induced rapid apoptosis and sustained tumor regression in xenograft models…
HOUSTON, Dec. 11, 2022 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in…
Clinically active across a wide dose range (2.15 to 24 mg) in a Phase 1…
“Austin Accident Lawyer” Andrew Traub shares how his firm has helped their clients get past…
Company Provides Comprehensive Clinical Update from Phase 1/2 Trial Tuspetinib Continues to Deliver Single Agent…
– ASH poster presentation summarizes preclinical data from SENTI-202, an off-the-shelf CAR-NK cell therapy candidate…
The HAVEN 7 study was designed to further confirm the benefit of preventative treatment (prophylaxis)…
The phase III COMMODORE 3 study of crovalimab met primary endpoints of transfusion avoidance and…